2VGO | date | ![]() |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | AD5, TPO | enzyme |
| ||||||||||||
note | 2VGO is a representative structure | ||||||||||||||
Gene Ontology ![]() |
| ||||||||||||||
Primary reference | Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells., D'Alise AM, Amabile G, Iovino M, Di Giorgio FP, Bartiromo M, Sessa F, Villa F, Musacchio A, Cortese R, Mol Cancer Ther. 2008 May;7(5):1140-9. PMID:18483302 |
Data retrieval |
![]() |
View 2VGO in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |